Edesa Biotech Reports Fiscal 2nd Quarter 2024 Results
Accesswire
*TORONTO, ON / ACCESSWIRE / May 10, 2024 /* Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused..
*TORONTO, ON / ACCESSWIRE / May 10, 2024 /* Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused..
The biotech company continues to offer hope to systemic lupus erythematosus (SLE) patients globally by sharing the latest..
SAN DIEGO--(BUSINESS WIRE)---- $ARCT #ClinicalTrial--Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”,..